NCT00695604撤回2 期
Repeated High-dose Inhaled Corticosteroids for Asthma
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Airflow inflammation.
研究概览
简要总结
The purpose of this study is to to compare the effects of high-dose Inhaled Corticosteroids (ICS) vs. placebo in adults with chronic stable asthma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
1
Placebo Comparator
Placebo Comparator
All patients assigned to this group will receive:
- Placebo via Metered Dose Inhaler (MDI).
- Albuterol via MDI.
干预措施: Placebo (Drug)
2
Active Comparator
Active Comparator
All patients assigned to this group will receive:
- Fluticasone via MDI.
- Albuterol via MDI.
干预措施: Fluticasone (Drug)
结局指标
主要结局
Airflow inflammation.
时间窗: Pre-study and post-study drug administration
次要结局
- Airflow obstruction.(Pre-study and post-study drug administration)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Evaluation of Inhaled Treatment in SinusitisSinusitisNCT01907204Cliniques universitaires Saint-Luc- Université Catholique de Louvain50
终止
不适用
Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at HomeAsthmaNCT01783132Orion Corporation, Orion Pharma142
已完成
不适用
Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)Lung DiseasesAsthmaNCT00319488National Heart, Lung, and Blood Institute (NHLBI)238
已完成
2 期
Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPDChronic Obstructive Pulmonary DiseaseNCT05607719University of Miami25
招募中
不适用
Evaluate the Therapeutic Effect of Inhaled Corticosteroid in Asthmatic ChildrenAsthmaNCT03487809National Taiwan University Hospital100